InflaRx N.V. Files 2024 Annual Report
Ticker: IFRX · Form: 20-F · Filed: Mar 20, 2025 · CIK: 1708688
Sentiment: neutral
Topics: annual-report, 20-f, pharmaceuticals
TL;DR
InflaRx N.V. dropped its 2024 20-F, check financials.
AI Summary
InflaRx N.V. filed its annual report on Form 20-F for the fiscal year ended December 31, 2024. The company, previously known as Fireman B.V. until June 6, 2017, is based in Jena, Germany, and operates in the pharmaceutical preparations sector. This filing serves as an annual update for the SEC.
Why It Matters
This filing provides investors and the public with a comprehensive overview of InflaRx N.V.'s financial performance, business operations, and risk factors for the fiscal year 2024.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not contain new material events or significant financial changes that would inherently increase risk.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 20250320 — Filing Date (The date the annual report was submitted to the SEC.)
Key Players & Entities
- InflaRx N.V. (company) — Filer of the 20-F
- Fireman B.V. (company) — Former name of InflaRx N.V.
- 20250320 (date) — Filing date of the 20-F
- 20241231 (date) — Fiscal year end date
FAQ
What is the primary purpose of this Form 20-F filing for InflaRx N.V.?
The primary purpose is to provide an annual report for the fiscal year ended December 31, 2024, as required by the Securities Exchange Act of 1934.
When did InflaRx N.V. change its name from Fireman B.V.?
InflaRx N.V. changed its name from Fireman B.V. on June 6, 2017.
What is InflaRx N.V.'s Standard Industrial Classification (SIC) code?
InflaRx N.V.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is InflaRx N.V. headquartered?
InflaRx N.V. is headquartered at Winzerlaer Str. 2, Jena, Germany.
What is the SEC file number for InflaRx N.V.'s 20-F filing?
The SEC file number for this 20-F filing is 001-38283.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 20, 2025 regarding InflaRx N.V. (IFRX).